![Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation](https://www.researchgate.net/profile/William-Wachsman/publication/5690363/figure/fig2/AS:267778821193769@1440854854634/Event-free-survival-EFS-and-OS-median-OS-not-yet-reached-at-a-median-of-23-weeks_Q320.jpg)
Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation
![The kinetics of reduction of minimal residual disease impacts on duration of response and survival of patients with acute myeloid leukemia | Leukemia The kinetics of reduction of minimal residual disease impacts on duration of response and survival of patients with acute myeloid leukemia | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.leu.2404313/MediaObjects/41375_2006_Article_BF2404313_Fig1_HTML.gif)
The kinetics of reduction of minimal residual disease impacts on duration of response and survival of patients with acute myeloid leukemia | Leukemia
![Overall survival (OS) and progression-free survival (PFS) in patients... | Download Scientific Diagram Overall survival (OS) and progression-free survival (PFS) in patients... | Download Scientific Diagram](https://www.researchgate.net/publication/328751184/figure/fig4/AS:958789662560280@1605604677804/Overall-survival-OS-and-progression-free-survival-PFS-in-patients-undergoing-deferred.png)
Overall survival (OS) and progression-free survival (PFS) in patients... | Download Scientific Diagram
![Survival estimates plotted by NCCN categories of risk. (A) Two-year OS... | Download Scientific Diagram Survival estimates plotted by NCCN categories of risk. (A) Two-year OS... | Download Scientific Diagram](https://www.researchgate.net/publication/335065872/figure/fig1/AS:916090204983297@1595424333930/Survival-estimates-plotted-by-NCCN-categories-of-risk-A-Two-year-OS-was-42-58-74.png)
Survival estimates plotted by NCCN categories of risk. (A) Two-year OS... | Download Scientific Diagram
![Patients demographics and clinico-biologic characteristics according to... | Download Scientific Diagram Patients demographics and clinico-biologic characteristics according to... | Download Scientific Diagram](https://www.researchgate.net/profile/Francesco-Lanza-3/publication/335065872/figure/tbl1/AS:916090204999685@1595424333997/Patients-demographics-and-clinico-biologic-characteristics-according-to-treatment-received_Q640.jpg)
Patients demographics and clinico-biologic characteristics according to... | Download Scientific Diagram
![IJMS | Free Full-Text | The Implementation of Mass Spectrometry-Based Proteomics Workflows in Clinical Routines of Acute Myeloid Leukemia: Applicability and Perspectives IJMS | Free Full-Text | The Implementation of Mass Spectrometry-Based Proteomics Workflows in Clinical Routines of Acute Myeloid Leukemia: Applicability and Perspectives](https://www.mdpi.com/ijms/ijms-21-06830/article_deploy/html/images/ijms-21-06830-g001.png)
IJMS | Free Full-Text | The Implementation of Mass Spectrometry-Based Proteomics Workflows in Clinical Routines of Acute Myeloid Leukemia: Applicability and Perspectives
![PDF) Outcomes of synchronous systemic and central nervous system (CNS) involvement of diffuse large B-cell lymphoma are dictated by the CNS disease: a collaborative study of the Australasian Lymphoma Alliance: Synchronous CNS PDF) Outcomes of synchronous systemic and central nervous system (CNS) involvement of diffuse large B-cell lymphoma are dictated by the CNS disease: a collaborative study of the Australasian Lymphoma Alliance: Synchronous CNS](https://www.researchgate.net/profile/Dipti-Talaulikar/publication/334005541/figure/fig2/AS:829665350524931@1574819042253/A-Progression-free-survival-according-to-receipt-of-consolidative-AuSCT-in-first_Q320.jpg)
PDF) Outcomes of synchronous systemic and central nervous system (CNS) involvement of diffuse large B-cell lymphoma are dictated by the CNS disease: a collaborative study of the Australasian Lymphoma Alliance: Synchronous CNS
![Overall survival (OS) and progression-free survival (PFS) from time of... | Download Scientific Diagram Overall survival (OS) and progression-free survival (PFS) from time of... | Download Scientific Diagram](https://www.researchgate.net/publication/328751184/figure/fig3/AS:958789662568489@1605604677701/Overall-survival-OS-and-progression-free-survival-PFS-from-time-of-ASCT-Median-OS_Q640.jpg)
Overall survival (OS) and progression-free survival (PFS) from time of... | Download Scientific Diagram
![PDF) Predicting poor peripheral blood stem cell collection in patients with multiple myeloma receiving pre-transplant induction therapy with novel agents and mobilized with cyclophosphamide plus granulocyte-colony stimulating factor: Results from a Gruppo PDF) Predicting poor peripheral blood stem cell collection in patients with multiple myeloma receiving pre-transplant induction therapy with novel agents and mobilized with cyclophosphamide plus granulocyte-colony stimulating factor: Results from a Gruppo](https://i1.rgstatic.net/publication/275101627_Predicting_poor_peripheral_blood_stem_cell_collection_in_patients_with_multiple_myeloma_receiving_pre-transplant_induction_therapy_with_novel_agents_and_mobilized_with_cyclophosphamide_plus_granulocyt/links/559bdbd808ae898ed650a749/largepreview.png)
PDF) Predicting poor peripheral blood stem cell collection in patients with multiple myeloma receiving pre-transplant induction therapy with novel agents and mobilized with cyclophosphamide plus granulocyte-colony stimulating factor: Results from a Gruppo
![A clinician's guide to double hit lymphomas - Cheah - 2015 - British Journal of Haematology - Wiley Online Library A clinician's guide to double hit lymphomas - Cheah - 2015 - British Journal of Haematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/a72270fc-d8ee-4e76-b307-acbdd8a1b8d5/bjh.2015.168.issue-6.cover.jpg?trick=1678676375017)
A clinician's guide to double hit lymphomas - Cheah - 2015 - British Journal of Haematology - Wiley Online Library
![Cancers | Free Full-Text | Use of Measurable Residual Disease to Evolve Transplant Policy in Acute Myeloid Leukemia: A 20-Year Monocentric Observation Cancers | Free Full-Text | Use of Measurable Residual Disease to Evolve Transplant Policy in Acute Myeloid Leukemia: A 20-Year Monocentric Observation](https://www.mdpi.com/cancers/cancers-13-01083/article_deploy/html/images/cancers-13-01083-g001.png)
Cancers | Free Full-Text | Use of Measurable Residual Disease to Evolve Transplant Policy in Acute Myeloid Leukemia: A 20-Year Monocentric Observation
Varios - Estetica Y Emancipacion Fantasma Fetiche Y Fantasmagoria-2 | PDF | Galileo Galilei | Cuerpos del sistema solar
![Minocycline for symptom reduction in patients with multiple myeloma during maintenance therapy: a phase II placebo-controlled randomized trial | Request PDF Minocycline for symptom reduction in patients with multiple myeloma during maintenance therapy: a phase II placebo-controlled randomized trial | Request PDF](https://i1.rgstatic.net/publication/350574669_Minocycline_for_symptom_reduction_in_patients_with_multiple_myeloma_during_maintenance_therapy_a_phase_II_placebo-controlled_randomized_trial/links/6066a60e458515614d2b843e/largepreview.png)
Minocycline for symptom reduction in patients with multiple myeloma during maintenance therapy: a phase II placebo-controlled randomized trial | Request PDF
![Overall survival (OS) and progression-free survival (PFS) from time of... | Download Scientific Diagram Overall survival (OS) and progression-free survival (PFS) from time of... | Download Scientific Diagram](https://www.researchgate.net/publication/328751184/figure/fig3/AS:958789662568489@1605604677701/Overall-survival-OS-and-progression-free-survival-PFS-from-time-of-ASCT-Median-OS.png)
Overall survival (OS) and progression-free survival (PFS) from time of... | Download Scientific Diagram
![European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasias | Leukemia European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasias | Leukemia](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41375-018-0209-7/MediaObjects/41375_2018_209_Fig1_HTML.png)
European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasias | Leukemia
![Enhancement of terbium efficiency by gallium and copper co-doping in (Pr, Nd)-Fe-B sintered magnets - ScienceDirect Enhancement of terbium efficiency by gallium and copper co-doping in (Pr, Nd)-Fe-B sintered magnets - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1002072122001090-ga1.jpg)